News for XTL Biopharmaceuticals Ltd. (XTLB)

News for XTL Biopharmaceuticals Ltd.
Date Headline
Dec 13, 2017 07:30 AM Wired News – Medigene Announced Collaboration with RXi Pharma to Further Improve its Therapeutic T Cells
Dec 06, 2017 12:08 PM XTL Biopharmaceuticals Ltd. Regains Compliance with Nasdaq's Minimum Stockholders' Equity Listing Requirements
Nov 27, 2017 10:30 AM XTL Biopharmaceuticals Reports Third Quarter 2017 Financial Results
Oct 06, 2017 07:30 AM Corporate News Blog - Catabasis Pharma Shares Positive Results from Phase-2 MoveDMD Trials for Assessing Edasalonexent for Treatment of Duchenne Muscular Dystrophy
Oct 05, 2017 07:50 AM Earnings Review and Free Research Report: DelMar Missed Earnings Expectations
Sep 26, 2017 09:23 AM XTL Biopharmaceuticals Reports First Half 2017 Financial Results & Provides Clinical and Operational Update
Sep 12, 2017 09:00 AM XTL Biopharmaceuticals Unveils Additional Expanded hCDR1 Preclinical Data for the Treatment of Sjogren's Syndrome
Jul 11, 2017 07:00 AM Featured Company News – Inotek Pharma Announces Top-line Results of Phase-2 FDC Trial of Trabodenoson and Offers Corporate Update
Jun 15, 2017 09:00 AM XTL Biopharmaceuticals Reports First Quarter 2017 Financial Results & Provides Clinical and Operational Update
Apr 27, 2017 09:50 AM XTL Biopharmaceuticals Appoints Mr. Alex Rabinovich to its Board of Directors